Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities

Ítems similars

• Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
  per: Zhao, Na, et al.
  Publicat: (2020)
• Development of hydroxamate-based histone deacetylase inhibitors of bis-substituted aromatic amides with antitumor activities
  per: Ge, Di, et al.
  Publicat: (2019)
• Design, synthesis, and evaluation of hydroxamic acid-based molecular probes for in vivo imaging of histone deacetylase (HDAC) in brain
  per: Wang, Changning, et al.
  Publicat: (2013)
• Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents
  per: An, Ran, et al.
  Publicat: (2018)
• Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
  per: García, Santiago, et al.
  Publicat: (2020)